Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...